Avanos Medical Still Anticipates FY24 Revenue From Cont. Ops Of $685M - $705M (Est $695.40M), Adjusted EPS From Cont. Ops Of Between $1.30 - $1.45 (Est $1.38)
Avanos Medical Still Anticipates FY24 Revenue From Cont. Ops Of $685M - $705M (Est $695.40M), Adjusted EPS From Cont. Ops Of Between $1.30 - $1.45 (Est $1.38)
Avanos Medical仍預期FY24的營業收入爲6850萬美元至7050萬美元（預估爲695.40M美元），來自持續經營活動的調整每股收益在1.30美元至1.45美元之間（預估爲1.38美元）。
Avanos Medical Still Anticipates FY24 Revenue From Cont. Ops Of $685M - $705M (Est $695.40M), Adjusted EPS From Cont. Ops Of Between $1.30 - $1.45 (Est $1.38)
Avanos Medical仍預期FY24的營業收入爲6850萬美元至7050萬美元（預估爲695.40M美元），來自持續經營活動的調整每股收益在1.30美元至1.45美元之間（預估爲1.38美元）。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。